SCHEMBL8775736

SCHEMBL8775736

C[C@]12C[C@H](O[N+](=O)[O-])[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O[N+](=O)[O-]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.52
MAPK1 P28482 3/20 0.52
TSHR P16473 3/20 0.52
AKR1C3 P42330 1/20 0.52
LMNA P02545 5/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
CYP3A4 P08684 3/20 0.49
ALOX15 P16050 2/20 0.49
RECQL P46063 2/20 0.49
BRCA1 P38398 1/20 0.49
PTPN11 Q06124 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
STS P08842 3/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
ESR1 P03372 8/20 0.47
ESR2 Q92731 6/20 0.47
MAPT P10636 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10356258 1.00 HSD17B10 (0.52) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL8775817 0.90 ESR1 (0.58) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL1415037 0.80 CA2 (0.35) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL13645679 0.79 HSD17B10 (0.49) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL6541320 0.76 HSD17B10 (0.69) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL6541316 0.76 HSD17B10 (0.69) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL6854847 0.75 ESR1 (0.64) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL6854850 0.75 ESR1 (0.64) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL9144315 0.75 ESR1 (0.64) HSD17B10MAPK1TSHRAKR1C3LMNA
SCHEMBL7923895 0.75 ESR1 (0.61) HSD17B10TSHRLMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0719276-B1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE US HEALTH (US) 1997-11-26 EP claimed
WO-1995007925-A1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-03-23 WO claimed